Greenwich Stock Market Sentiment

GLSI
 Stock
  

USD 8.47  0.06  0.70%   

Greenwich investor sentiment overview provides quick insight into current market opportunities from investing in Greenwich Lifesciences. The current market sentiment together Greenwich Lifesciences' historical and current headlines can help investors to time the market. Many technical investors use Greenwich Lifesciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please check Greenwich Lifesciences Hype Analysis, Greenwich Lifesciences Correlation and Greenwich Lifesciences Performance.
  
Refresh
Greenwich Lifesciences stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Greenwich daily returns and investor perception about the current pice of Greenwich Lifesciences as well as its diversification or hedging effects on your existing portfolios.

Greenwich Latest Sentiment Indicators

200 Day MA
23.2
Short Percent
0.11
Short Ratio
1.51
Shares Short Prior Month
347.5 K
50 Day MA
9.96
52 Week Low
6.82
Shares Short
367 K
over two months ago at simplywall.st         
Insider Buying The Greenwich LifeSciences, Inc. CEO, CFO Director Just Bought US100k Worth Of Shares...
Simply Wall St News at Macroaxis
over two months ago at www.macroaxis.com         
Purchase by Daugherty Frank Joseph of 1000 shares of Greenwich Lifesciences
Macroaxis News
over two months ago at www.macroaxis.com         
Purchase by Patel Snehal of 6000 shares of Greenwich Lifesciences
Macroaxis News
over two months ago at www.macroaxis.com         
Purchase by Patel Snehal of 6000 shares of Greenwich Lifesciences
Macroaxis News
over two months ago at www.macroaxis.com         
Purchase by Thompson Jaye of 500 shares of Greenwich Lifesciences
Macroaxis News
over two months ago at finance.yahoo.com         
Greenwich LifeSciences Presents Phase IIb Data, Published at AACR 2022, Further Supporting the Role ...
Yahoo News
over two months ago at www.defenseworld.net         
Greenwich LifeSciences Upgraded to Hold at Zacks Investment Research - Defense World
news
over two months ago at www.globenewswire.com         
Fluidigm Completes 250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc....
news
over three months ago at www.investorsobserver.com         
Is Greenwich Lifesciences Inc Stock at the Top of the Biotechnology Industry - InvestorsObserver
Investors Business Daily at Macroaxis
over three months ago at www.investorsobserver.com         
How Will the Market React to Greenwich Lifesciences Inc Stock Getting a Bullish Rating - InvestorsOb...
Investors Business Daily at Macroaxis
over three months ago at www.marketbeat.com         
-0.07 EPS Expected for Greenwich LifeSciences, Inc. This Quarter - MarketBeat
Marketbeat News
over three months ago at finance.yahoo.com         
Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial, Patent Filings, AACR M...
Yahoo News
over three months ago at www.marketscreener.com         
Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial, Patent Filings, AACR M...
news
over three months ago at www.macroaxis.com         
Purchase by Patel Snehal of 5500 shares of Greenwich Lifesciences
Macroaxis News
over three months ago at www.investorsobserver.com         
Greenwich Lifesciences Inc Stock What Does the Chart Say Friday - InvestorsObserver
Investors Business Daily at Macroaxis
There is far too much social signal, news, headlines, and media speculation about Greenwich Lifesciences that is available to investors today. That information is available publicly through Greenwich media outlets and privately through word of mouth or via Greenwich internal channels. However, regardless of the origin, that massive amount of Greenwich data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Greenwich Lifesciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Greenwich Lifesciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Greenwich Lifesciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Greenwich Lifesciences alpha.

Greenwich Lifesciences Performance against DOW

 Price Growth (%)  
      Timeline 
1
Purchase by Thompson Jaye of 500 shares of Greenwich Lifesci...04/20/2022
2
Purchase by Patel Snehal of 6000 shares of Greenwich Lifesci...04/21/2022
3
Purchase by Patel Snehal of 6000 shares of Greenwich Lifesci...04/22/2022
4
Purchase by Daugherty Frank Joseph of 1000 shares of Greenwi...04/26/2022
5
Insider Buying The Greenwich LifeSciences, Inc. CEO, CFO Dir...04/28/2022
6
Other05/16/2022
7
EPS Reported05/20/2022
8
Purchase by Patel Snehal of 6774 shares of Greenwich Lifesci...06/03/2022
9
Purchase by Patel Snehal of 9250 shares of Greenwich Lifesci...06/06/2022
10
Purchase by Patel Snehal of 6000 shares of Greenwich Lifesci...06/08/2022
11
Purchase by Patel Snehal of 4500 shares of Greenwich Lifesci...06/10/2022
12
Purchase by Patel Snehal of 12000 shares of Greenwich Lifesc...06/13/2022
13
Purchase by Patel Snehal of 12000 shares of Greenwich Lifesc...06/15/2022
14
Purchase by Patel Snehal of 8000 shares of Greenwich Lifesci...06/17/2022
15
Unclassified Event06/22/2022
16
Acquisition by Hallock Kenneth of 41349 shares of Greenwich ...06/24/2022
17
Purchase by Patel Snehal of 6465 shares of Greenwich Lifesci...06/27/2022
Please check Greenwich Lifesciences Hype Analysis, Greenwich Lifesciences Correlation and Greenwich Lifesciences Performance. Note that the Greenwich Lifesciences information on this page should be used as a complementary analysis to other Greenwich Lifesciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Greenwich Stock analysis

When running Greenwich Lifesciences price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Is Greenwich Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
110.9 M
Return On Assets
-0.15
Return On Equity
-0.24
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Greenwich Lifesciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.